Vertex Pharmaceuticals (VRTX) Q3 2026 Earnings

3AugConfirmed
Q4 2025
Q1 2026
Q2 2026
Q3 2026
4.24
4.53
4.82
5.11

Details

Expected EPS
4.740907
Actual EPS
4.73
Surprise EPS
-0.01
Surprise Percent
+0.23%

Description

Vertex Pharmaceuticals (VRTX) has reported earnings of 4.73 per share for Q3 2026.

0 Comments

Share your thoughts